The 3 Junior Biotech to Watch Out for in 2017
Despite the broader sector of the market underperforming in comparison to other market groups, investors are continuing to test the waters of junior biotech. In 2016, there was a massive attack on industry price fixing ... [Read]
President and CEO of VBI Vaccines Set to Present at Jefferies 2017 Global Healthcare Conference
VBI Vaccines Inc. (NASDAQ:$VBIV), a biopharmaceutical company headquartered in Cambridge, MA, announced today that VBI’s President and CEO, Jeff Baxter, will be presenting at the Jefferies 2017 Global Healthcare Conference on Friday, June 9, 2017 ... [Read]
Pomerantz Law Firm Launches Class Action Lawsuit Against Lion Biotechnologies, Inc.
New York City-based law firm, Pomerantz LLP, has just announced that a class action lawsuit has been filed against Lion Biotechnologies, Inc. (NASDAQ:$IOVA) and certain of its officers. The lawsuit was filed in United States ... [Read]